TrialJournal of investigative medicine : the official publication of the American Federation for Clinical Research2024

Rosiglitazone improves insulin resistance but does not improve exercise capacity in individuals with impaired glucose tolerance: A randomized clinical study.

Layla A Abushamat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.